Chesley Taft & Associates LLC lessened its holdings in Express Scripts Holding (NASDAQ:ESRX) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 74,615 shares of the company’s stock after selling 2,774 shares during the quarter. Chesley Taft & Associates LLC’s holdings in Express Scripts were worth $5,569,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Burt Wealth Advisors grew its position in shares of Express Scripts by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the period. Bank of Nova Scotia Trust Co. acquired a new stake in shares of Express Scripts during the 3rd quarter worth approximately $120,000. Monroe Bank & Trust MI lifted its holdings in shares of Express Scripts by 74.8% in the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after purchasing an additional 970 shares in the last quarter. Capstone Investment Advisors Netherlands B.V. lifted its holdings in shares of Express Scripts by 49.3% in the 2nd quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock worth $179,000 after purchasing an additional 924 shares in the last quarter. Finally, Nelson Roberts Investment Advisors LLC bought a new position in shares of Express Scripts in the 3rd quarter worth $193,000. Institutional investors and hedge funds own 88.19% of the company’s stock.
In other news, VP Glen D. Stettin sold 3,448 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total transaction of $262,048.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Glen D. Stettin sold 3,449 shares of the business’s stock in a transaction dated Thursday, January 11th. The stock was sold at an average price of $81.00, for a total value of $279,369.00. Following the transaction, the vice president now directly owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The disclosure for this sale can be found here. Insiders have sold a total of 17,001 shares of company stock valued at $1,249,505 in the last ninety days. Insiders own 0.68% of the company’s stock.
Express Scripts Holding (NASDAQ ESRX) traded down $1.08 during mid-day trading on Thursday, reaching $78.10. The company’s stock had a trading volume of 4,468,735 shares, compared to its average volume of 3,910,000. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. The stock has a market cap of $44,850.00, a price-to-earnings ratio of 12.97, a PEG ratio of 0.88 and a beta of 0.87. Express Scripts Holding has a 1-year low of $55.80 and a 1-year high of $83.49.
Express Scripts declared that its Board of Directors has approved a stock buyback program on Monday, December 18th that allows the company to buyback 45,000,000 shares. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s management believes its shares are undervalued.
A number of brokerages recently issued reports on ESRX. Mizuho set a $67.00 target price on Express Scripts and gave the stock a “hold” rating in a report on Tuesday, October 24th. Sanford C. Bernstein cut Express Scripts from a “market perform” rating to an “underperform” rating and raised their price objective for the company from $55.80 to $77.50 in a research note on Tuesday. Raymond James Financial restated a “sell” rating on shares of Express Scripts in a research note on Friday, December 15th. Robert W. Baird restated a “buy” rating and set a $92.00 price objective (up from $81.00) on shares of Express Scripts in a research note on Tuesday, January 9th. Finally, Royal Bank of Canada upgraded Express Scripts from a “sector perform” rating to an “outperform” rating and set a $68.00 price objective on the stock in a research note on Wednesday. Six analysts have rated the stock with a sell rating, eight have assigned a hold rating, nine have given a buy rating and two have given a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $78.23.
COPYRIGHT VIOLATION WARNING: This report was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/02/express-scripts-holding-esrx-position-cut-by-chesley-taft-associates-llc.html.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.